Pharmaceuticals

Growing Prevalence Of Chronic Diseases In Children Boosts Pediatric Vaccine Market Is Supporting Development Across The Pediatric Vaccine Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Pediatric Vaccine Market By 2030?

The pediatric vaccine market has seen rapid expansion in recent years. This market is projected to grow from $57.51 billion in 2025 to $65.01 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The historical growth of this market can be attributed to the rising prevalence of preventable childhood diseases, government-led immunization campaigns, advancements in vaccine adjuvants, growing awareness of pediatric health, and the expansion of cold chain infrastructure.

The pediatric vaccine market is projected to experience substantial expansion over the upcoming years, with an anticipated increase to $107.8 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.5%. This projected growth is driven by factors such as advancements in mRNA and DNA vaccine technologies, increased funding for pediatric vaccine research and development (R&D), the incorporation of digital health monitoring, the broadening of healthcare infrastructure in developing economies, and collaborations between biotechnology companies and international health bodies. Key trends during this period encompass a greater emphasis on improving vaccine access in less affluent areas, the increasing use of combination vaccines, the extension of school-based immunization initiatives, the creation of new pediatric vaccines for uncommon diseases, and an increase in public-private collaborations for vaccine research.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Which Core Factors Are Supporting The Expansion Of The Pediatric Vaccine Market?

The pediatric vaccines market is experiencing growth driven by the escalating occurrence of pediatric diseases. This expansion is significantly influenced by the rising prevalence of chronic conditions, such as tuberculosis, diphtheria, and pneumonia, among individuals aged 15 and below, which heightens the risk of severe disease outcomes and complications from infectious diseases in affected children and adolescents. As an illustration, the UK’s National Health Service reported in June 2024 that 3,615,330 individuals registered with a general practitioner were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, representing an 18% increase from 3,065,825 cases in 2022. Pediatric diseases themselves encompass a range of disorders affecting children from infancy to puberty, varying in severity from moderate to acute or chronic, and pediatric vaccinations play a crucial role in their prevention and control, protecting children from numerous infectious illnesses. Further exemplifying this trend, GOV.UK, a UK government department, indicated in February 2024 that cases of tuberculosis (TB) in England increased by 10.7% in 2023, rising from 4,380 in 2022 to 4,850. Therefore, the increasing prevalence of pediatric diseases is a primary catalyst for the growth in the pediatric vaccines market.

How Is Segment Classification Applied In The Pediatric Vaccine Market?

The pediatric vaccine market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

What Trends Are Affecting The Growth Of The Pediatric Vaccine Market?

Leading companies in the pediatric vaccine market are concentrating on securing product approvals to better serve the requirements of their current consumers. ABRYSVO is a vaccine that has been authorized by the FDA for use in pregnant women to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in children up to 6 months of age. For instance, in August 2023, Pfizer Inc., a US-based pharmaceutical manufacturing company, announced the U.S. FDA approval of Pfizer’s ABRYSVO vaccine. This approval is for the prevention of Respiratory Syncytial Virus (RSV) in infants through the active immunization of pregnant women between 32-36 weeks gestational age. This vaccine is the first and only maternal vaccination approved in the United States designed to help protect newborns against lower respiratory tract illness (LRTD) and severe LRTD caused by RSV from birth to six months of age.

Who Are The Companies Shaping The Pediatric Vaccine Market Landscape?

Major companies operating in the pediatric vaccine market are Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Daiichi Sankyo, CSL Limited, Sinopharm, Walvax Biotechnology, Fosun Pharma, MCM Vaccine Company, Seqirus, Johnson & Johnson, Connaught Laboratories Inc., Wyeth-Ayerst, Ataulfo de Paiva Foundation, Bio-Manguinhos – Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

Access The Complete Pediatric Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Which Region Commands The Largest Share Of The Pediatric Vaccine Market?

North America was the largest region in the pediatric vaccine market in 2025. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pediatric Vaccine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

Browse Through More Reports Similar to the Global Pediatric Vaccine Market 2026, By The Business Research Company

Pediatric Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Adult Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795